association of the serum vascular endothelial growth factor levels with benign prostate hyperplasia and prostate malignancies

نویسندگان

mohammad reza sharif department of pediatrics, kashan university of medical sciences, kashan, ir iran

amirreza shaabani department of urology, kashan university of medical sciences, kashan, ir iran

hossein mahmoudi department of urology, kashan university of medical sciences, kashan, ir iran

hassan nikoueinejad department of nephrology and urology research center, baqiyatallah university of medical sciences, tehran, ir iran; department of nephrology and urology research center, baqiyatallah university of medical sciences, baqiyatallah hospital, mollasadra ave., vanak sq., p.o. box: 19395-5487, tehran, ir iran. tel: +98-2181262073, fax: +98-3615551112

چکیده

background: recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. objectives: this study was aimed to determine whether serum vascular endothelial growth factor (vegf) levels would be a prognostic marker or risk assessment factor in patients with prostate cancer and to investigate whether it could differentiate cancerous tissue from benign prostate hyperplasia (bph). patients and methods: we enrolled 44 patients with prostate cancer, 57 patients with bph, and 57 healthy individuals. serum vegf levels was measured by elisa and was compared among all groups; then, its correlation with psa and gleason score in cancerous group was assessed. in addition, by using receiver operating characteristic (roc) curve and area under curve (auc), we determined the sensitivity and specificity of vegf as well as combined variable of vegf and psa as a diagnostic marker of prostate cancer. results: serum vegf level was significantly higher in patients with prostate cancer in comparison to the other groups (p value < 0.001); however, it was not different between bph and control groups. only in cancerous group a significant correlation between vegf and psa was found (r = 0.425, p = 0.004). assessing the risk of prostate cancer, we found a powerful correlation between the vegf alone as well as the combination of vegf and psa with prostate cancer. conclusions: vegf may be a diagnostic biomarker of prostate cancer. in addition, it may differentiate the cancerous tissue from bph. we suggest that vegf combined with psa may be used as a screening test of prostate cancer.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Association of the Serum Vascular Endothelial Growth Factor Levels With Benign Prostate Hyperplasia and Prostate Malignancies

BACKGROUND Recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. OBJECTIVES This study was aimed to determine whether serum vascular endothelial growth factor (VEGF) levels would be a prognostic marker or risk assessment factor in patients with prostate cancer and to investigate whether it could differentiate cancerous tissue fro...

متن کامل

Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer.

BACKGROUND Tumor angiogenesis is an absolute requirement for tumor growth and a prognostic factor for various malignant neoplasms. Recent reports in the literature have addressed the importance of the VEGF system in benign prostatic hyperplasia (BPH) and adenocarcinoma, however the results are controversial. The aim of the present study was to determine and compare the levels of VEGF expression...

متن کامل

Evaluation of Plasma Interleukin-8 Concentration in Patients with Prostate Cancer and Benign Prostate Hyperplasia

Background: Prostate specific antigen (PSA) has been used as a screening test for the early detection of prostate cancer (PC) for many years. Although the introduction of PSA test led to a considerable increase in reported prostate cancer cases, there is still some controversy over the sensitivity and specificity of this marker in distinguishing PC patients from those with benign prostate hyper...

متن کامل

Methodological Concerns Regarding Levels of Vascular Endothelial Growth Factor (VEGF) in Serum of Women with Endometriosis

s:865:"We read with interest the manuscript entitled "Serum and peritoneal fluid levels of vascular endothelial growth factor in women with endometriosis" recently published in the International Journal of Fertility and Sterility (1). The authors measured the levels of vascular endothelial growth factor in serum and peritoneal fluid of 179 women, 90 of whom were diagnosed with endometriosis, an...

متن کامل

Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer.

OBJECTIVE To study the association and possible relationship of prostate inflammation with benign prostatic hyperplasia (BPH), and prostate cancer. METHODS The medical records and pathological findings of all Saudi patients who underwent transrectal ultrasound guided prostatic needle biopsies in King Abdulaziz University Medical City, Jeddah,Kingdom of Saudi Arabia from June 2003 to June 2008...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
nephro-urology monthly

جلد ۶، شماره ۳، صفحات ۰-۰

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023